8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
Thermo Fisher reports 10% second-quarter revenue growth and $6.03 adjusted EPS
Filed with the SEC on · Summarized by InvestorsBot
Thermo Fisher Scientific reported second-quarter 2026 revenue of $11.99 billion for the period ended June 27, up 10% year over year, including 5% organic growth; GAAP diluted EPS rose 9% to $4.68 and adjusted EPS increased 13% to $6.03. The company repurchased $1.0 billion of stock during the quarter, announced the divestiture of its microbiology business, and said it would provide updated 2026 guidance on its July 23 earnings call.